Condition

Cataract (3)

Cystoid Macular Edema (1)

Diabetes Mellitus (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 3 (2)

n/a (1)

Sponsor

Alcon Research (1)

Maastricht University Medical Center (1)

Sintetica SA (1)

Collaborator

European Society of Cataract and Refractive Surgeons (1)

Intervention

acrysof® iq extended depth of focus iol (1)

acrysof® iq monofocal iol (1)

bevacizumab (1)

bromfenac (1)

cataract surgery (1)

chloroprocaine 3% (1)

dexamethasone (1)

tetracaine 0.5% (1)

triamcinolone acetonide (1)

Study Documents

Intervention Type

drug (2)

device (1)

procedure (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

cataract

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cataract Trial in Italy, Slovakia, Spain (Chloroprocaine 3%, Tetracaine 0.5%)

Completed

Cataract

Chloroprocaine 3%
Tetracaine 0.5%

Bologna, Italy
+26 more

Apr 19, 2021

Cataract Trial in Worldwide (ACRYSOF® IQ Extended Depth of Focus IOL, ACRYSOF® IQ Monofocal IOL, Cataract surgery)

Completed

Has Results

Cataract

ACRYSOF® IQ Extended Depth of Focus IOL
+2 more

Sydney, New South Wales, Australia
+20 more

Mar 25, 2020

Cystoid Macular Edema, Cataract, Diabetes Trial in Worldwide (Bromfenac, Dexamethasone, Bevacizumab)

Completed

Cystoid Macular Edema
+2 more

Bromfenac
+3 more

Vienna, Austria
+15 more

Apr 13, 2017